Leverage Shares 2x Long CRML Daily ETF (CRMU)
Live price chart, market sentiment, and community perspectives for Leverage Shares 2x Long CRML Daily ETF (NASDAQ: CRMU).
Live price chart, market sentiment, and community perspectives for Leverage Shares 2x Long CRML Daily ETF (NASDAQ: CRMU).
On our trading desk, we look at CRMU as a classic single-stock daily reset trap. With a 1-year beta reported at an astronomical 9.42 and a drawdown exceeding 60-70% since its February 2026 inception, holding this past the intraday session is financial suicide. The compounding decay in a volatile critical metals market completely overwhelms any long-term thesis.
Market sentiment across forums and risk monitors points to a heavily hostile environment for CRMU. Even though Critical Metals Corp feeds into clean energy and resource security narratives, the macro backdrop with a VIX sitting around 22 to 25 creates a brutal environment for a 2x leveraged vehicle executed through total return swaps with counterparties like Marex and Cantor.
From a risk management standpoint, the Sharpe ratio of -1.82 and Sortino of -2.76 underscore why this asset class receives a weak risk profile for multi-week holding periods. The structure relies on total return swaps allocating up to 100% of assets, meaning investors face structural headwinds independent of the underlying stock's day-to-day fluctuations.
When evaluating liquidity for execution algorithms, analysts must factor in the friction points. CRMU has an extremely thin profile with roughly $1.58 million in assets under management and a daily dollar volume near $192K. Paired with bid-ask spreads as wide as 5.06%, trading friction alone will massacre short-term alpha if entry and exit parameters aren't meticulously timed.
In structuring quantitative reviews for leveraged single-stock funds, we advise checking the statutory filings closely. With the March 2026 supplement confirming full asset allocation into swap agreements and option premiums, traders must treat CRMU strictly as a tactical instrument rather than a buy-and-hold equity replacement.
Explore plasma cleansing, somatic organ swaps, and BCI.